Inactive Instrument

News MDxHealth SA Euronext Bruxelles

Equities

Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering	Mar. 12	AQ
Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering	Mar. 12	CI
Piper Sandler Adjusts Price Target on MDxHealth to $7 From $6, Maintains Overweight Rating	Mar. 07	MT
MDxHealth SA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Mar. 06	CI
Transcript : MDxHealth SA, Q4 2023 Earnings Call, Mar 06, 2024	Mar. 06
Earnings Flash (MDXH) MDXHEALTH Posts Q4 Revenue $19.4M	Mar. 06	MT
Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results	Mar. 06	AQ
MDxHealth SA Maintains Earnings Guidance for the Year 2024	Mar. 06	CI
MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6	Feb. 21	AQ
Mdxhealth Announces Resignation of Board Member	Feb. 16	AQ
MDxHealth SA Announces Jan Pensaert Steps Down from its Board of Directors	Feb. 16	CI
MDxHealth Preliminary Q4 Revenue Tops Consensus; 2024 Outlook Exceeds Estimates; Shares Jump After Hours	Jan. 08	MT
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2023 Revenues and Issues 2024 Revenue Guidance	Jan. 08	AQ
MDxHealth SA Provides Earnings Guidance for the Fourth Quarter and Full Year 2023 and Year 2024	Jan. 08	CI

No results for this search